Novel genetic associations for blood pressure identified via gene-alcohol interaction in up to 570K individuals across multiple ancestries
- PMID: 29912962
- PMCID: PMC6005576
- DOI: 10.1371/journal.pone.0198166
Novel genetic associations for blood pressure identified via gene-alcohol interaction in up to 570K individuals across multiple ancestries
Abstract
Heavy alcohol consumption is an established risk factor for hypertension; the mechanism by which alcohol consumption impact blood pressure (BP) regulation remains unknown. We hypothesized that a genome-wide association study accounting for gene-alcohol consumption interaction for BP might identify additional BP loci and contribute to the understanding of alcohol-related BP regulation. We conducted a large two-stage investigation incorporating joint testing of main genetic effects and single nucleotide variant (SNV)-alcohol consumption interactions. In Stage 1, genome-wide discovery meta-analyses in ≈131K individuals across several ancestry groups yielded 3,514 SNVs (245 loci) with suggestive evidence of association (P < 1.0 x 10-5). In Stage 2, these SNVs were tested for independent external replication in ≈440K individuals across multiple ancestries. We identified and replicated (at Bonferroni correction threshold) five novel BP loci (380 SNVs in 21 genes) and 49 previously reported BP loci (2,159 SNVs in 109 genes) in European ancestry, and in multi-ancestry meta-analyses (P < 5.0 x 10-8). For African ancestry samples, we detected 18 potentially novel BP loci (P < 5.0 x 10-8) in Stage 1 that warrant further replication. Additionally, correlated meta-analysis identified eight novel BP loci (11 genes). Several genes in these loci (e.g., PINX1, GATA4, BLK, FTO and GABBR2) have been previously reported to be associated with alcohol consumption. These findings provide insights into the role of alcohol consumption in the genetic architecture of hypertension.
Conflict of interest statement
The authors have read the journal's policy and the authors of this manuscript have the following competing interests: Bruce M. Psaty (BMP) serves on the DSMB of a clinical trial funded by Zoll Lifecor and on the Steering Committee of the Yale Open Data Access Project funded by Johnson & Johnson. Barbara V. Howard (BVH) has a contract from National Heart, Lung, and Blood Institute (NHLBI). Brenda W.J.H. Penninx (BWJHP) has received research funding (non-related to the work reported here) from Jansen Research and Boehringer Ingelheim. Mike A. Nalls (MAN) is supported by a consulting contract between Data Tecnica International LLC and the National Institute on Aging (NIA), National Institutes of Health (NIH), Bethesda, MD, USA. MAN also consults for Illumina Inc., the Michael J. Fox Foundation, and the University of California Healthcare. MAN also has commercial affiliation with Data Tecnica International, Glen Echo, MD, USA. Mark J. Caulfield (MJC) has commercial affiliation and is Chief Scientist for Genomics England, a UK government company. OHF is supported by grants from Metagenics (on women's health and epigenetics) and from Nestlé (on child health). Peter S. Sever (PSS) is financial supported from several pharmaceutical companies which manufacture either blood pressure lowering or lipid lowering agents, or both, and consultancy fees. Paul W. Franks (PWF) has been a paid consultant in the design of a personalized nutrition trial (PREDICT) as part of a private-public partnership at Kings College London, UK, and has received research support from several pharmaceutical companies as part of European Union Innovative Medicines Initiative (IMI) projects. Terho Lehtimäki (TL) is employed by Fimlab Ltd. Ozren Polašek (OP) is employed by Gen‐info Ltd. There are no patents, products in development, or marked products to declare. All the other authors have declared no competing interests exist. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.
Figures
References
-
- O'Donnell MJ, Chin SL, Rangarajan S, Xavier D, Liu L, Zhang H, et al. Global and regional effects of potentially modifiable risk factors associated with acute stroke in 32 countries (INTERSTROKE): a case-control study. Lancet. 2016;388(10046):761–75. doi: 10.1016/S0140-6736(16)30506-2 . - DOI - PubMed
-
- Collaborators GBDRF. Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016;388(10053):1659–724. doi: 10.1016/S0140-6736(16)31679-8 . - DOI - PMC - PubMed
-
- Writing Group M, Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, et al. Heart Disease and Stroke Statistics-2016 Update: A Report From the American Heart Association. Circulation. 2016;133(4):e38–360. doi: 10.1161/CIR.0000000000000350 . - DOI - PubMed
-
- Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr., et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003;289(19):2560–72. doi: 10.1001/jama.289.19.2560 . - DOI - PubMed
-
- Muntner P, Carey RM, Gidding S, Jones DW, Taler SJ, Wright JT Jr., et al. Potential U.S. Population Impact of the 2017 American College of Cardiology/American Heart Association High Blood Pressure Guideline. Circulation. 2017. doi: 10.1161/CIRCULATIONAHA.117.032582 . - DOI - PMC - PubMed
Publication types
MeSH terms
Grants and funding
- P30 ES010126/ES/NIEHS NIH HHS/United States
- MR/K002414/1/MRC_/Medical Research Council/United Kingdom
- U01 AG009740/AG/NIA NIH HHS/United States
- SP/13/2/30111/BHF_/British Heart Foundation/United Kingdom
- G0700931/MRC_/Medical Research Council/United Kingdom
- MR/L01341X/1/MRC_/Medical Research Council/United Kingdom
- G0601966/MRC_/Medical Research Council/United Kingdom
- MC_PC_U127561128/MRC_/Medical Research Council/United Kingdom
- R01 AG055406/AG/NIA NIH HHS/United States
- U01 DK062370/DK/NIDDK NIH HHS/United States
- R21 HL123677/HL/NHLBI NIH HHS/United States
- U01 AG023746/AG/NIA NIH HHS/United States
- BB/F019394/1/BB_/Biotechnology and Biological Sciences Research Council/United Kingdom
- R01 DK093757/DK/NIDDK NIH HHS/United States
- MC_UU_00007/10/MRC_/Medical Research Council/United Kingdom
- R01 DK117445/DK/NIDDK NIH HHS/United States
- R01 DK072193/DK/NIDDK NIH HHS/United States
- R01 HL086694/HL/NHLBI NIH HHS/United States
- MC_UU_12015/7/MRC_/Medical Research Council/United Kingdom
- MR/M013111/1/MRC_/Medical Research Council/United Kingdom
- MC_UP_1605/7/MRC_/Medical Research Council/United Kingdom
- MC_UU_12015/1/MRC_/Medical Research Council/United Kingdom
- R01 HL118305/HL/NHLBI NIH HHS/United States
- P30 DK020572/DK/NIDDK NIH HHS/United States
- MC_UU_12015/5/MRC_/Medical Research Council/United Kingdom
- R01 MD012765/MD/NIMHD NIH HHS/United States
- WT_/Wellcome Trust/United Kingdom
- P20 GM121334/GM/NIGMS NIH HHS/United States
- P01 CA196569/CA/NCI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
